We are very pleased to welcome 5 new hires.
Marleen Hereygers, PhD started as R&D Director, Project Management & Clinical Development. She started her career in a small CRO, but over the past 20 years gained work expertise in Pharma, Biotech, Medical Device and Central Lab environment in a variety of positions within Clinical Development (Phase I-III, including product launch) and Project Management Office. Marleen is very comfortable working in a regulated environment, in close collaboration with co-development partners and cross-functional teams.
Emilyne Blattes, PhD joined as R&D Manager, Scientific Development and CMC. In the past 5 years, she gained experience in early stage development and CTA-enabling trajectory of SMEs, including regulatory writing and clinical trial management. She has a global view on projects as she combines the biological/medical sides and the technical CMC dimension. Emilyne will operate from Paris.
Eric Ciamporcero, PhD started as R&D Manager Scientific Development. In the past 5 years, he worked at the interface between preclinical and clinical development, leading drug discovery and development programs in startup and large pharmaceutical companies. Eric is a team player with a strong background in oncology, combining experience in managing projects with strategic thinking.
Ann Hawinkel joined as Office Assistant. Over the past 2 decades Ann worked as a sales executive. She supports the team with contract management and is responsible for back office support at 2 Bridge. Ann takes care of office facilities to ensure a comfortable working environment for all colleagues.
Joeri Heymans, MSc, started as Finance and HR Operations Assistant Manager. In the past 4 years, he gained experience in the finance field by working in the banking and energy sector. He’s very interested in the financial picture and investments of companies. At 2 Bridge, Joeri is responsible for the daily follow-up of the Finance and HR Operations.